Citadel Advisors - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365A951. A total of 2 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2016$8,000
-70.4%
12,000
-62.5%
0.00%
Q1 2016$27,000
+3.8%
32,000
+23.6%
0.00%
Q4 2015$26,000
+766.7%
25,900
+979.2%
0.00%
Q3 2015$3,000
-78.6%
2,400
-68.8%
0.00%
Q1 2015$14,000
-50.0%
7,700
-49.7%
0.00%
Q4 2014$28,000
+2700.0%
15,300
+2960.0%
0.00%
Q3 2014$1,000
-95.2%
500
-91.2%
0.00%
Q2 2014$21,000
-73.1%
5,700
-66.7%
0.00%
Q1 2014$78,000
+23.8%
17,100
+5.6%
0.00%
Q4 2013$63,000
+21.2%
16,200
+40.9%
0.00%
Q3 2013$52,000
-40.9%
11,500
-36.1%
0.00%
Q2 2013$88,00018,0000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 100$8,0000.00%
Citadel Advisors 2,400$3,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders